The surgical management of menorrhagia

Human Reproduction Update

Volumn 8, Issue 1, 2002, Pages 68-78

  Abbott, Jason A ^a,d   Garry, Ray ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b TEESSIDE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

Endometrial ablation; Hysterectomy; Menorrhagia; Surgery; Uterine artery embolization

Indexed keywords

DANAZOL; GESTAGEN; GONADORELIN DERIVATIVE; LEVONORGESTREL;

ARTICLE; COMPLICATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ENDOMETRIUM ABLATION; EXCISION; FEMALE; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INTERVENTIONAL RADIOLOGY; LAPAROSCOPY; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS DISEASE;

ARTERIES; DRUG DELIVERY SYSTEMS; EMBOLIZATION, THERAPEUTIC; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; MENORRHAGIA; PROGESTINS; UTERINE NEOPLASMS; UTERUS;

EID: 0036166434     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/8.1.68     Document Type: Article

References (156)

1. Novacept endometrial ablation: Clinical outcomes to date
2. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: Outcome at four years
3. Endometrial rollerball ablation
4. Uterine thermal balloon therapy for the treatment of menorrhagia: The first 300 patients from a multi-centre study. International Collaborative Uterine Thermal Balloon Working Group
5. Endometrial ablation: A series of 568 patients treated over an 11 year period
6. Hysteroscopic treatment of symptomatic submucous myomata uteri with the Nd:YAG laser
7. Fatal acute glycine and sorbitol toxicity during operative hysteroscopy
8. Absorption of glycine irrigation solution during transcervical resection of the endometrium
9. A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia
10. Is balloon ablation as effective as endometrial electroresection in the treatment of menorrhagia
11. Absorption of irrigating fluid during transcervical resection of the endometrium
12. Has endometrial ablation replaced hysterectomy for the treatment of dysfunctional uterine bleeding? National figures
13. Transcervical resection of the endometrium
14. An agenda for research into uterine artery embolisation: Results of an expert panel conference
15. Guidelines in gynaecology: Evaluation in menorrhagia and in urinary incontinence
16. Medium term follow up of women with menorrhagia treated by rollerball endometrial ablation
17. Sources of variation in menstrual blood loss
18. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for the treatment of heavy menstrual loss
19. Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes
20. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: A randomised trial
21. A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding
22. Resectoscopic myomectomy
23. One-year results of the vesta system for endometrial ablation
24. Managing menorrhagia with endometrial resection
25. General Practitioners' referrals to specialist out-patient clinics
26. Quality of life and patient satisfaction following treatment for menorrhagia
27. Patients' preferences and general practitioners decisions in the treatment of menorrhagia
28. Managing menorrhagia
29. Endometrial resection versus vaginal hysterectomy for menorrhagia: Long term clinical and quality of life outcomes
30. Endometrectomy, laparoscopically assisted vaginal hysterectomy, vaginal or abdominal hysterectomy: Reasoned indications
31. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States: The Collaborative review of Sterilisation
32. Nd YAG laser hysteroscopic myomectomy
33. Endometrial laser interstitial hyperthermy: A potential modality for endometrial ablation
34. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: A large randomised, double blind study
35. Endometrial laser intrauterine thermotherapy: The first series of 100 patients observed for 1 year
36. Early endometrial carcinoma and incidental finding after endometrial resection. Case report
37. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the treatment of menorrhagia
38. Endometrial ablation in the treatment of menorrhagia
39. Prospective randomised clinical trial of laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy
40. Identifying the indications for laparoscopically assisted vaginal hysterectomy: A prospective comparison with abdominal hysterectomy in patients with symptomatic uterine fibroids
41. A preliminary study of factors influencing perception of menstrual blood loss volume
42. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia
43. Photodynamic therapy and its applications in gynaecology
44. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia
45. Hysteroscopic alternatives to hysterectomy
46. Distension media and fluid systems
47. Good practice with endometrial ablation
48. Endometrial ablation and resection: Validation of a new surgical concept
49. Management of menorrhagia
50. A uterine distension system to prevent fluid absorption during Nd:YAG laser endometrial ablation
51. Six hundred endometrial laser ablations
52. A comparison of goserelin and danazol as endometrial thinning agents prior to endometrial laser ablation
53. Psychiatric disorder and gynaecological symptoms in middle aged women: A community survey
54. Angiographic embolisation in the management of haemorrhagic complications of pregnancy
55. Intrauterine laser surgery
56. Hysteroscopic endometrial ablation
57. The hysteroscopic management of endometrial leiomyotosis
58. Laser photovaporisation of the endometrium for the treatment of menorrhagia
59. Endometrial ablation by hysteroscopic instillation of hot saline solution
60. Uterine artery embolisation for the treatment of uterine fibroids
61. Preliminary experience with uterine artery embolisation for uterine fibroids
62. An audit of abdominal hysterectomy over a decade in a district hospital
63. Thermal balloon and rollerball ablation to treat menorrhagia: Two-year results of a multicenter, prospective, randomized, clinical trial
64. Obstetric and non malignant gynaecologic bleeding: Treatment with angiographic embolisation
65. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis and after hysterectomy
66. Menstrual blood loss - A population study. Variation at different ages and attempts to define normality
67. Women's concerns with hormone replacement therapy compliance issues
68. Electroresection of fibroids
69. Paresis following internal iliac embolisation
70. Endometrial ablation
71. The alternatives to hysterectomy
72. The validity of continuous automated fluid monitoring during intra-uterine surgery, luxury or necessity
73. Cavaterm thermal balloon ablation for the treatment of menorrhagia
74. Urinary bladder necrosis following selective embolisation of the internal iliac artery
75. Assessment of menstrual blood loss using a pictorial chart
76. Microwave endometrial ablation: Development, clinical trials and outcomes at three years
77. Volume 1: Finished consultant episodes by diagnosis, operation and specialty
78. Selective uterine artery embolisation as a primary treatment for symptomatic leiomyomata uteri
79. Changes in serum electrolytes after transcervical resection of the endometrium and submucous fibroids with use of glycine 1.5% for uterine irrigation
80. Transcatheter gelfoam embolisation in abdominal, retroperitoneal and pelvic haemorrhage
81. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss
82. Endometrial ablation to control excessive uterine bleeding
83. Effectiveness of hysterectomy
84. Ruptured ectopic pregnancy in an amenorrheic woman after transcervical resection of the endometrium
85. Development and validation of the menorrhagia outcomes questionnaire
86. Abdominal hysterectomy should not be considered as a primary method for uterine removal. A prospective randomised study of 100 patients referred for hysterectomy
87. Progesterone/progesterone releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding (Cochrane review)
88. Endometrial resection and ablation versus hysterectomy for heavy menstruation
89. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids
90. Complications from uterine distension during hysteroscopy
91. Endometrial ablation for the treatment of menorrhagia: A comparison of patients with normal, enlarged and fibroid uteri
92. Management of menorrhagia
93. Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy: A prospective, randomised, multicentre study
94. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist buserelin
95. Iron deficiency anaemia in pre-menopausal women
96. CY payment policies and relative value unit adjustments, 58813-59187. FR Doc. 98-29181
97. Thermal balloon and rollerball ablation to treat menorrhagia: A multicentre comparison
98. A new technique for and additional experience with hysteroscopic resection of submucous fibroids
99. Excision of submucous fibroids with hysteroscopic control
100. The endometrial ablator: A new instrument
101. Endometrial resection for the treatment of menorrhagia
102. A Medical Research Council randomised trial of endometrial resection versus hysterectomy of menorrhagia
103. A randomised prospective trial comparing laparoscopic and abdominal hysterectomy
104. Pregnancy following rollerball endometrial ablation
105. A national survey of the complications of endometrial destruction for menstrual disorders: The MISTLETOE study
106. Rollerball ablation of the endometrium
107. A comparison of endometrial laser ablation using the Nd:Yag laser or electrosurgical techniques
108. Risk of hysterectomy after 1000 consecutive laser ablations
109. Treatment of functional menorrhagia by radio-frequency induced thermal endometrial ablation
110. Transcervical endometrial cryoablation for menorrhagia
111. A randomised prospective study of laparoscopic vaginal hysterectomy versus abdominal hysterectomy each with bilateral salpingo-ophorectomy
112. Transcervical resection of the endometrium: A review of 400 consecutive patients
113. A cost analysis of endometrial ablation, abdominal hysterectomy, vaginal hysterectomy and laparoscopic-assisted vaginal hysterectomy in the treatment of primary menorrhagia
114. Preoperative embolization of uterine fibroma. Preliminary results
115. Arterial embolisation to treat uterine myomata
116. Value of preoperative embolisation of uterine fibromyoma: A report of a multicentre series of 31 cases
117. The role of menstrual blood loss measurements in management of complaints of excessive menstrual bleeding
118. Hysterectomy as a treatment for dysfunctional uterine bleeding
119. Assessment of menstrual blood loss using a pictorial chart: A validation study
120. A comparison of the efficacy of danazol, norethisterone, cyproterone acetate and medroxyprogesterone acetate in endometrial ablation prior to ablation: A pilot study
121. Is laparoscopic hysterectomy a waste of time?
122. Outcome of pregnancy following endometrial ablation
123. Hormonale Vorbehandlung fur die Endometriumablation - Ergebnisse einer prospektiven vergleichsstudie
124. Angiographic arterial embolisation in the management of postoperative vaginal haemorrhage
125. Morbidity statistics from general practice, fourth national study 1991-92
126. An economic evaluation of transcervical resection versus abdominal for the treatment of menorrhagia
127. Randomised trial comparing hysterectomy and transcervical endometrial resection: Effect on health related quality of life and costs two years after surgery
128. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents
129. Preoperative therapy in preparation for endometrial ablation
130. Prediction of endometrial ablation success according to perioperative findings
131. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment
132. The effect of hysterectomy on the age at ovarian failure: Identification of a subgroup of women with premature loss of ovarian function and literature review
133. Hysterectomy as a treatment for dysfunctional uterine bleeding: Editorial
134. Endometrial ablation using a distensible multi-electrode balloon
135. A prospective randomised trial on the effect of pre-operative endometrial inhibition on the long-term outcome of transcervical resection
136. Pre and postoperative therapy with GnRH agonist in preparation for endometrial resection
137. Randomised comparison of laparoscopy-assisted vaginal hysterectomy with standard vaginal hysterectomy in an outpatient setting
138. A multicentre randomised comparison of laparoscopically assisted vaginal hysterectomy and abdominal hysterectomy in abdominal hysterectomy candidates
139. Treatment of large uterine fibroids
140. Radio-frequency induced endometrial ablation: An update
141. The etiologic and pathologic factors in a series of 1,741 fibromyomas of the uterus
142. Rollerball coagulation of the endometrium
143. Hysteroscopic removal of submucous leiomyomas
144. Endometrial electroablation
145. Fatal septicaemia after fibroid embolisation
146. Uterine artery embolisation: An underused method of controlling pelvic haemorrhage
147. Treatment with a gonadotrophin releasing hormone agonist before endometrial resection: A multicentre, randomised controlled trial
148. Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: Results of a multicentre, randomised controlled trial
149. The epidemiology of hysterectomy: Findings of a large cohort study
150. Experience with 800 hysteroscopic endometrial ablations
151. Economic evaluation of hysteroscopic endometrial ablation versus vaginal hysterectomy for menorrhagia
152. Clinical trial of the uterine thermal balloon for treatment of menorrhagia
153. A double-blind randomised trial of leuprorelin acetate prior to hysterectomy for dysfunctional uterine bleeding
154. Hysteroscopic endometrial ablation using free heated saline for the treatment of menorrhagia
155. Complications associated with the absorption of hysteroscopic fluid media
156. Uterine artery embolisation for the management of leiomyomas: Quality of life assessment and clinical response